EUVIMEDEUVIMED entdecken
Crossref

Molecular Point-of-Care Diagnostics for Vector-Borne Pathogens: Biotechnological Innovations and Challenges in Field Implementation

Alireza Zare-Karizi, Bita Ghaderi, Mohammad Mehdi Sedaghat, Seyed Hojjat Khatamifar, Mohammad Javad Dehnavi, Baher Esmaeil-Pour, Hamidreza Basseri

Journal of Arthropod-Borne Diseases · 03.11.2026

DOI: 10.18502/jad.v20i3.23172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Arthropod-Borne Diseases, online erschienen am 03.11.2026. Verfasst von Alireza Zare-Karizi und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Centralized diagnostics can delay detection of vector-borne pathogens. Molecular point-of-care (mPOC) technologies may address this gap, but performance and field readiness remain uncertain.

Methods

This rapid systematic review followed Cochrane Diagnostic Test Accuracy guidance. PubMed, Scopus and Web of Science (Clarivate) were searched for 2020–2025 publications (13 September 2025). Two-by-two data were extracted or reconstructed, and sensitivity and specificity were recalculated with 95% Wilson confidence in­ter­vals. Studies were classified by setting, assessed using the real-time connectivity, ease of specimen collection, afford­able, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliverable to end-users (REAS­SURED) criteria, and appraised with Quality Assessment of Diagnostic Accuracy Studies–2. Heterogeneity led to narrative synthesis.

Results

1,964 records yielded 22 studies: 11 malaria, 6 leishmaniasis and 5 arboviral infections. Twenty-one stud­ies provided two-by-two data, yielding 26 non-overlapping analyses. One study reported sensitivity only (86.4%, 95% con­fidence interval 75.5–93.0%) and one analysis was not reconstructable. Median sample size was 100 (in­terquartile range 76.5–161.5; range 13–490). Thirteen analyses reported 100% sensitivity or specificity, but 9 had lower confi­dence lim­its below 90%. Four studies evaluated point-of-care tests. Based on lower confidence limits, 8 met sensi­tivity and 5 met specificity REASSURED thresholds; 6 met real-time connectivity and 7 met ease of spec­imen col­lection. Seventeen (77.3%) reported no cost data. Conclusions: mPOC technologies are promising, but evidence is dominated by laboratory or near-laboratory stud­ies with imprecise estimates. Multicenter field evaluations, standardized reporting including costs and complete two-by-two data are needed before integration.

Zitieren

APA

Zare-Karizi, A., Ghaderi, B., Sedaghat, M. M., Khatamifar, S. H., Dehnavi, M. J., Esmaeil-Pour, B., & Basseri, H. (2026). Molecular Point-of-Care Diagnostics for Vector-Borne Pathogens: Biotechnological Innovations and Challenges in Field Implementation. Journal of Arthropod-Borne Diseases. https://doi.org/10.18502/jad.v20i3.23172

Vancouver

Zare-Karizi A, Ghaderi B, Sedaghat MM, Khatamifar SH, Dehnavi MJ, Esmaeil-Pour B, et al. Molecular Point-of-Care Diagnostics for Vector-Borne Pathogens: Biotechnological Innovations and Challenges in Field Implementation. Journal of Arthropod-Borne Diseases. 2026. doi:10.18502/jad.v20i3.23172

BibTeX
@article{ZareKarizi2026,
  author = {Zare-Karizi, Alireza and Ghaderi, Bita and Sedaghat, Mohammad Mehdi and Khatamifar, Seyed Hojjat and Dehnavi, Mohammad Javad and Esmaeil-Pour, Baher and Basseri, Hamidreza},
  title = {Molecular Point-of-Care Diagnostics for Vector-Borne Pathogens: Biotechnological Innovations and Challenges in Field Implementation},
  journal = {Journal of Arthropod-Borne Diseases},
  year = {2026},
  doi = {10.18502/jad.v20i3.23172}
}
Kostenlos starten →